| SENS Snapshot | |
|---|---|
| Senseonics Holdings, Inc., a medical technology company, develops and markets continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company is headquartered in Germantown, Maryland. | |
| VALUATION DATA | |
| Market Capitalization | $220,820,000 | Price to Sales | 1.00 |
| Earnings per Share | $-0.1100 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $0.3992 |
| 52 Week High | $11.4 |
| 52 Week Low | $7.13 |
| 50-Day Moving Average | $8.65 |
| 200-Day Moving Average | $-4.032 |
| All data are from Alpha Vantage as of today. For more infomation on SENS see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search